Brief: Olema Pharmaceuticals Q3 Net Income USD -42.217 Million
10/11/2025 12:00
Nov 10 (Reuters) - Olema Pharmaceuticals Q3 operating expenses USD 45.877 million. Q3 income from operations USD -45.877 million
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary